MAT1A
Basic information
Region (hg38): 10:80271820-80289658
Links
Phenotypes
GenCC
Source:
- methionine adenosyltransferase deficiency (Strong), mode of inheritance: AR
- methionine adenosyltransferase deficiency (Strong), mode of inheritance: AD
- methionine adenosyltransferase deficiency (Strong), mode of inheritance: AR
- methionine adenosyltransferase deficiency (Supportive), mode of inheritance: AR
- methionine adenosyltransferase deficiency (Strong), mode of inheritance: AR
- methionine adenosyltransferase deficiency (Strong), mode of inheritance: AD
- methionine adenosyltransferase deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Methionine adenosyltransferase I/III deficiency | AD/AR | Biochemical | While the disorders frequently do not have severe sequelae, and therapy may not be required for many individuals, in some, dietary measures (eg, methionine restriction) may be beneficial; AdoMet therapy has also been described as beneficial | Biochemical; Neurologic | 1191305; 7229751; 7271238; 3812486; 3339126; 1683972; 1527987; 7573050; 7560086; 8770875; 9042912; 9482646; 12705496 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hepatic methionine adenosyltransferase deficiency (16 variants)
- not provided (6 variants)
- MAT1A-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAT1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 41 | 50 | ||||
missense | 10 | 127 | 145 | |||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 6 | 7 | 13 | |||
non coding | 54 | 25 | 40 | 119 | ||
Total | 18 | 10 | 187 | 66 | 46 |
Highest pathogenic variant AF is 0.0000197
Variants in MAT1A
This is a list of pathogenic ClinVar variants found in the MAT1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-80271857-G-A | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 12, 2018) | ||
10-80271923-A-G | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 13, 2018) | ||
10-80271961-C-T | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 13, 2018) | ||
10-80272040-A-G | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 12, 2018) | ||
10-80272054-C-T | Hepatic methionine adenosyltransferase deficiency | Likely benign (Jan 13, 2018) | ||
10-80272090-A-G | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 13, 2018) | ||
10-80272108-G-A | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Apr 27, 2017) | ||
10-80272120-C-G | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 13, 2018) | ||
10-80272181-C-CCCAGCCTGAA | Hepatic methionine adenosyltransferase deficiency | Benign (Jun 14, 2016) | ||
10-80272399-C-T | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 12, 2018) | ||
10-80272483-C-T | Hepatic methionine adenosyltransferase deficiency | Benign (Jan 13, 2018) | ||
10-80272484-A-G | Hepatic methionine adenosyltransferase deficiency | Benign (Jan 12, 2018) | ||
10-80272489-C-G | Hepatic methionine adenosyltransferase deficiency | Benign (Jan 13, 2018) | ||
10-80272513-A-G | Hepatic methionine adenosyltransferase deficiency | Likely benign (Jan 13, 2018) | ||
10-80272574-A-G | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 13, 2018) | ||
10-80272575-C-T | Hepatic methionine adenosyltransferase deficiency | Benign (Jan 12, 2018) | ||
10-80272589-G-C | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 13, 2018) | ||
10-80272681-G-C | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 13, 2018) | ||
10-80272689-G-C | Hepatic methionine adenosyltransferase deficiency | Benign (Jan 13, 2018) | ||
10-80272703-G-A | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 12, 2018) | ||
10-80272723-A-G | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 12, 2018) | ||
10-80272752-C-T | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jan 12, 2018) | ||
10-80272760-G-T | Hepatic methionine adenosyltransferase deficiency | Uncertain significance (Jun 14, 2016) | ||
10-80272785-TG-T | Hepatic methionine adenosyltransferase deficiency | Benign (Jun 14, 2016) | ||
10-80272799-T-A | Hepatic methionine adenosyltransferase deficiency | Benign (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAT1A | protein_coding | protein_coding | ENST00000372213 | 9 | 17865 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000810 | 0.985 | 125728 | 0 | 20 | 125748 | 0.0000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.65 | 166 | 238 | 0.698 | 0.0000157 | 2576 |
Missense in Polyphen | 53 | 108.73 | 0.48745 | 1142 | ||
Synonymous | -0.912 | 107 | 95.7 | 1.12 | 0.00000708 | 788 |
Loss of Function | 2.16 | 8 | 17.8 | 0.449 | 8.66e-7 | 208 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000616 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000879 | 0.0000879 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000135 | 0.000131 |
Other | 0.000328 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the formation of S-adenosylmethionine from methionine and ATP. The reaction comprises two steps that are both catalyzed by the same enzyme: formation of S-adenosylmethionine (AdoMet) and triphosphate, and subsequent hydrolysis of the triphosphate. {ECO:0000269|PubMed:10677294}.;
- Disease
- DISEASE: Methionine adenosyltransferase deficiency (MATD) [MIM:250850]: An inborn error of metabolism resulting in isolated hypermethioninemia. Most patients have no clinical abnormalities, although some neurologic symptoms may be present in rare cases with severe loss of methionine adenosyltransferase activity. {ECO:0000269|PubMed:10677294, ECO:0000269|PubMed:7560086, ECO:0000269|PubMed:8770875, ECO:0000269|PubMed:9042912}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Cysteine and methionine metabolism - Homo sapiens (human);Vitamin B12 Metabolism;Folate Metabolism;One Carbon Metabolism;Trans-sulfuration and one carbon metabolism;Methionine De Novo and Salvage Pathway;One carbon metabolism and related pathways;Ethanol effects on histone modifications;Methylation Pathways;Methylation;Phase II - Conjugation of compounds;Metabolism of amino acids and derivatives;methionine degradation;Biological oxidations;Metabolism;Methionine Cysteine metabolism;Selenoamino acid metabolism;Metabolism of ingested SeMet, Sec, MeSec into H2Se;S-adenosyl-L-methionine biosynthesis;methionine salvage cycle III;Sulfur amino acid metabolism;cysteine biosynthesis;superpathway of methionine degradation
(Consensus)
Recessive Scores
- pRec
- 0.376
Intolerance Scores
- loftool
- 0.0748
- rvis_EVS
- -0.78
- rvis_percentile_EVS
- 12.77
Haploinsufficiency Scores
- pHI
- 0.916
- hipred
- Y
- hipred_score
- 0.707
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.770
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mat1a
- Phenotype
- liver/biliary system phenotype; homeostasis/metabolism phenotype; immune system phenotype;
Gene ontology
- Biological process
- sulfur amino acid metabolic process;selenium compound metabolic process;S-adenosylmethionine biosynthetic process;one-carbon metabolic process;methionine catabolic process;methylation;protein homotetramerization
- Cellular component
- cytosol
- Molecular function
- methionine adenosyltransferase activity;ATP binding;identical protein binding;metal ion binding;selenomethionine adenosyltransferase activity